Using MRI to guide brain stimulation for memory improvement
Official title: Spatiotemporally Precise Neuromodulation by Transcranial Magnetic Stimulation Guided by Multimodal Neuroimaging
Run by Sunnybrook Health Sciences Centre · NCT06050603 · Data updated 2026-11-12
This study is testing a new way to boost memory by using MRI scans to guide brain stimulation for people with mild cognitive impairment and healthy individuals.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 160 (estimated) |
| Sponsor | Sunnybrook Health Sciences Centre Academic / other |
| Locations | 1 site (Toronto, Ontario) |
| Status | Recruiting |
| Started | September 7, 2023 |
| Main results expected | July 31, 2027 |
| Study ends | July 31, 2027 |
| Registry record updated | August 13, 2024 |
| Trial ID | NCT06050603 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include healthy adults aged 18-65 and individuals aged 50-80 with amnestic mild cognitive impairment.
✕Probably not a fit
Patients with a history of neurological impairments or those who are pregnant or breastfeeding may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study aims to develop a personalized approach to enhance brain activity using transcranial magnetic stimulation (TMS) guided by MRI and EEG. Participants will undergo MRI scans to identify specific brain areas for stimulation, and TMS will be applied to modulate activity in these regions. The study will involve multiple visits to Sunnybrook Health Sciences Centre, where participants will be screened and assessed for eligibility. The goal is to improve the effectiveness of TMS in individuals with mild cognitive impairment and healthy participants.
Why it matters
Potential benefit: If successful, this approach could lead to improved memory function in patients with mild cognitive impairment.
How similar studies have gone: While TMS has been used in various contexts, this specific approach combining MRI and EEG for targeted stimulation is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria for Healthy participants: * Ages between 18 and 65 years; * Healthy with no history of neurological impairment; * Normal or correct-to-normal vision. Inclusion Criteria for aMCI patients: * Age 50-80 years; * MCI clinical criteria: (a) self- or informant-reported cognitive complaint; (b) preserved independence in functional abilities; and (c) absence of dementia; * Objective cognitive impairment supported by the following measures of general cognitive function: (a) Mini-Mental State Exam (MMSE) 24-27 (inclusive); (b) Montreal Cognitive Assessment (MoCA) 18-26 (inclusive); or (c) Clinical Dementia Rating Scale score of 0.5; * Normal or correct-to-normal vision. Exclusion Criteria for all participants: * Women who are pregnant or breastfeeding; * History of seizure (childhood febrile seizures are acceptable and these subjects may be included in the study), history of epilepsy in self or first degree relatives, stroke, brain tumor, brain surgery, head injury, known structural brain lesion; * Have metal in the eye or skull area, brain stimulator, surgical metal, clips in the brain, cochlear implants, mental fragments in the eye, as these make TMS unsafe; * Have non-MRI compatible metal in the body, for example metallic (forromagnetic) implants (e.g., cardiac pacemaker, aneurysm clip); * Subjects who are uncomfortable in small closed spaces (have claustrophobia), unable to lie comfortably supine for up to 1 hour, and would feel uncomfortable in the MRI machine; * Participation in any other study involving non-invasive brain stimulation less than two weeks ago; * Abnormal findings on neurological examination that we will perform.
Where it's running
-
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada Recruiting
Study contacts
- Principal investigator: Fa-Hsuan Lin, PhD — Sunnybrook Research Institute
- Study coordinator: Fa-Hsuan Lin, PhD
- Email: fhlin@sri.utoronto.ca
- Phone: 416-480-6100
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using deep learning and Raman spectroscopy for early cancer diagnosis
This study is trying to see if a new deep learning tool using blood samples can help spot early signs of different types of cancer, like colorectal and gastric cancers, in both healthy people and those already diagnosed.
-
Using brain stimulation to improve learning and decision-making
This study is testing if a type of brain stimulation can help healthy adults learn better and make smarter decisions.
-
Understanding how light affects sleep and body clocks based on age and sex
This study is testing how different ages and sexes respond to light and how that affects sleep and body clocks in healthy people.
-
Developing and validating tasks for learning and decision-making
This study is testing new tasks to see how people with substance use disorders learn and make decisions, using activities that may involve brain scans to understand their responses better.
-
Collection of blood and urine samples from healthy individuals for future research
This study is collecting blood and urine samples from healthy adults to help with future medical research.
-
Improving MRI techniques using scans from healthy individuals
This study is testing new MRI scanning techniques on healthy volunteers to see if they can improve how we measure and understand different parts of the body.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.